This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What’s underneath that macro “healthcare” index number of 67 is a precipitous decline in the past year for Americans’ trust in hospitals, compared with biotech, pharma, consumer healthcare, and even health insurance — all of which grew in trust between 2018 and 2019, but not so with the hospital segment of U.S.
As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.
The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018.
IQVIA’s national prescription data revealed that prescriptions for mental health drugs grew 8% since 2019 — with a 33% rise among girls under 19. There is another data point in the study on women’s health and prescriptions — for ADHD drugs. Health Populi’s Hot Points: Life expectancy in the U.S.
When this occurred, it didn’t cause more than a ripple of interest outside biotech. A 2018 national survey found that 39% of U.S. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S.
prescriptions per person in 2018, two in three of which treated chronic conditions. In a call with analysts this week in which I participated, Murray Aitken discussed the report which looks back at 2018 and forward to 2023 with scenarios about what the U.S. Americans consumed 17.6 Welcome to Medicine Use and Spending in the U.S. ,
That logic was bolstered by a finding in the 2018 Edelman Trust Barometer finding more U.S. consumers trusted the biotechhealth industry segment compared with the pharmaceutical segment. Right now they’re very science- and research-forward versus very business-forward.”. Why was this the case?
adults in April-May 2018 for this survey. Health Populi’s Hot Points: Americans draw a very big distinction between biotech and pharma when it comes to trust, this year’s Edelman Trust Barometer found. For people earning under $30K, most people believe healthcare creates as many problems as it solves.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content